Rafael B. Erlich

808 total citations
13 papers, 699 citations indexed

About

Rafael B. Erlich is a scholar working on Molecular Biology, Oncology and Biomaterials. According to data from OpenAlex, Rafael B. Erlich has authored 13 papers receiving a total of 699 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Biomaterials. Recurrent topics in Rafael B. Erlich's work include Histone Deacetylase Inhibitors Research (3 papers), Protein Degradation and Inhibitors (3 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Rafael B. Erlich is often cited by papers focused on Histone Deacetylase Inhibitors Research (3 papers), Protein Degradation and Inhibitors (3 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Rafael B. Erlich collaborates with scholars based in Australia, Brazil and United States. Rafael B. Erlich's co-authors include Maria Kavallaris, Thomas P. Davis, Cyrille Boyer, Hien Duong, Mia C. Åkerfeldt, Joshua A. McCarroll, Tanya Dwarte, Mathew W. Jones, Yang Li and Alexander Macmillan and has published in prestigious journals such as ACS Nano, Cancer Research and Chemical Communications.

In The Last Decade

Rafael B. Erlich

13 papers receiving 688 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rafael B. Erlich Australia 10 367 197 169 81 79 13 699
Ti Tong China 12 307 0.8× 132 0.7× 138 0.8× 120 1.5× 60 0.8× 33 717
Edward L. Mertz United States 16 418 1.1× 112 0.6× 127 0.8× 100 1.2× 55 0.7× 27 1.0k
Sangram S. Parelkar United States 17 330 0.9× 166 0.8× 232 1.4× 88 1.1× 211 2.7× 23 822
Yu Jin Jang South Korea 17 514 1.4× 303 1.5× 136 0.8× 89 1.1× 86 1.1× 36 1.2k
Cuifeng Wang China 15 481 1.3× 232 1.2× 140 0.8× 64 0.8× 35 0.4× 31 887
Mia C. Åkerfeldt Australia 11 325 0.9× 107 0.5× 107 0.6× 102 1.3× 43 0.5× 11 712
Shey-Cherng Tzou Taiwan 15 263 0.7× 143 0.7× 100 0.6× 97 1.2× 58 0.7× 34 625
Christian Ché Canada 6 650 1.8× 213 1.1× 444 2.6× 177 2.2× 40 0.5× 11 1.1k
Christine Gajewski United States 5 279 0.8× 194 1.0× 364 2.2× 30 0.4× 45 0.6× 5 793
Akinori Nagamitsu Japan 6 208 0.6× 174 0.9× 290 1.7× 83 1.0× 49 0.6× 11 482

Countries citing papers authored by Rafael B. Erlich

Since Specialization
Citations

This map shows the geographic impact of Rafael B. Erlich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rafael B. Erlich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rafael B. Erlich more than expected).

Fields of papers citing papers by Rafael B. Erlich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rafael B. Erlich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rafael B. Erlich. The network helps show where Rafael B. Erlich may publish in the future.

Co-authorship network of co-authors of Rafael B. Erlich

This figure shows the co-authorship network connecting the top 25 collaborators of Rafael B. Erlich. A scholar is included among the top collaborators of Rafael B. Erlich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rafael B. Erlich. Rafael B. Erlich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
McCarroll, Joshua A., Tanya Dwarte, Huricha Baigude, et al.. (2015). Therapeutic targeting of polo-like kinase 1 using RNA-interfering nanoparticles (iNOPs) for the treatment of non-small cell lung cancer. Oncotarget. 6(14). 12020–12034. 52 indexed citations
2.
McCarroll, Joshua A., Pei Pei Gan, Rafael B. Erlich, et al.. (2014). TUBB3 /βIII-Tubulin Acts through the PTEN/AKT Signaling Axis to Promote Tumorigenesis and Anoikis Resistance in Non–Small Cell Lung Cancer. Cancer Research. 75(2). 415–425. 80 indexed citations
3.
Boyer, Cyrille, Phoebe A. Phillips, Rafael B. Erlich, et al.. (2013). Effective Delivery of siRNA into Cancer Cells and Tumors Using Well-Defined Biodegradable Cationic Star Polymers. Molecular Pharmaceutics. 10(6). 2435–2444. 95 indexed citations
4.
Basuki, Johan S., Hien Duong, Alexander Macmillan, et al.. (2013). Using Fluorescence Lifetime Imaging Microscopy to Monitor Theranostic Nanoparticle Uptake and Intracellular Doxorubicin Release. ACS Nano. 7(11). 10175–10189. 151 indexed citations
5.
Duong, Hien, Rafael B. Erlich, Yang Li, et al.. (2012). Intracellular nitric oxide delivery from stable NO-polymeric nanoparticle carriers. Chemical Communications. 49(39). 4190–4192. 125 indexed citations
6.
Erlich, Rafael B., Danny Rickwood, Liliana Endo‐Munoz, et al.. (2011). Preclinical evaluation of dual PI3K-mTOR inhibitors and histone deacetylase inhibitors in head and neck squamous cell carcinoma. British Journal of Cancer. 106(1). 107–115. 49 indexed citations
7.
Saunders, Nicholas A., et al.. (2011). Abstract 2559: Preclinical evaluation of dual PI3K-mTOR inhibitors and histone deacetylase inhibitors in head and neck squamous cell carcinoma. Cancer Research. 71(8_Supplement). 2559–2559. 1 indexed citations
8.
Maciel, Renata de Moraes, et al.. (2010). Analysis of Pluripotent Stem Cells by using Cryosections of Embryoid Bodies. Journal of Visualized Experiments. 12 indexed citations
9.
Maciel, Renata de Moraes, et al.. (2010). Analysis of Pluripotent Stem Cells by using Cryosections of Embryoid Bodies. Journal of Visualized Experiments. 1 indexed citations
10.
Erlich, Rafael B., Danny Rickwood, William B. Coman, Nicholas A. Saunders, & Alexander Guminski. (2008). Valproic acid as a therapeutic agent for head and neck squamous cell carcinomas. Cancer Chemotherapy and Pharmacology. 63(3). 381–389. 34 indexed citations
11.
Erlich, Rafael B., Suzana Assad Kahn, Flávia Regina Souza Lima, et al.. (2007). STI1 promotes glioma proliferation through MAPK and PI3K pathways. Glia. 55(16). 1690–1698. 79 indexed citations
12.
Erlich, Rafael B., Cláudio C. Werneck, Paulo A.S. Mourão, & Rafael Linden. (2003). Major glycosaminoglycan species in the developing retina: synthesis, tissue distribution and effects upon cell death. Experimental Eye Research. 77(2). 157–165. 16 indexed citations
13.
Erlich, Rafael B., et al.. (1999). Synchronous Paget's sarcoma of tibiae in which Paget's disease was limited to these bones. Skeletal Radiology. 28(10). 599–603. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ti Tong Breakdown of academic impact, for papers by Edward L. Mertz Breakdown of academic impact, for papers by Sangram S. Parelkar Breakdown of academic impact, for papers by Yu Jin Jang Breakdown of academic impact, for papers by Cuifeng Wang Breakdown of academic impact, for papers by Mia C. Åkerfeldt Breakdown of academic impact, for papers by Shey-Cherng Tzou Breakdown of academic impact, for papers by Christian Ché Breakdown of academic impact, for papers by Christine Gajewski Breakdown of academic impact, for papers by Akinori Nagamitsu
Rankless by CCL
2026